Medtronic plc (MDT) Stock
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Medtronic plc
Medtronic plc is led by CEO Geoffrey Straub Martha, employs 95,000 people, headquartered in Galway, US, publicly traded since 1973.
Medtronic plc (MDT) stock trades at $95.41 with a market capitalization of $122.05B. The stock is valued at a price-to-earnings (P/E) ratio of 21.67, price-to-book of 2.26, price-to-sales of 3.02. Over the past 52 weeks the stock has ranged between $73.31 and $106.33, and currently trades 10.3% below its 52-week high. It pays a dividend yielding 3.25%.
On profitability, Medtronic plc generates a return on equity (ROE) of 10.60%, return on capital employed of 8.33%, an operating margin of 17.76%, a net profit margin of 13.93%.
In its most recent fiscal year, Medtronic plc reported annual revenue of $36.4B, net profit of $4.8B. Over the last 5 fiscal years, revenue grew at an average annual rate of 3.8%, and net profit grew at an average annual rate of 5.9%. Over that span net profit grew faster than revenue, so net margin widened.
The balance sheet shows a debt-to-equity ratio of 0.56, a current ratio of 1.85, total assets of $91.7B, $2.2B in cash and equivalents.
MDT has an average daily trading volume of 14,231,397 shares, a beta of 0.57 (historically less volatile than the overall market).
Medtronic plc by the numbers, 2016–2026
Compounded, revenue has grown 3.8% a year over five years, 5.2% over three, 8.4% over the last twelve months. Net profit was $4.8B in 2026.
The most recent net margin is 13.93%. On a trailing twelve-month basis to Mar '26, revenue is $36.4B and net profit $4.8B.
Borrowings fell from $31.0B to $0, cash from operations was $7.3B in the latest year, positive in 10 of the last 11.
Return on equity has averaged 8.2% over five years, and was 9.7% in the most recent year.
The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.
Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.
Medtronic plc (MDT) — frequently asked questions
What is Medtronic plc (MDT) stock price today?
Medtronic plc (MDT) is currently trading at $95.41, down 1.22% today.
What is MDT P/E ratio?
Medtronic plc's P/E ratio is 21.67. This is between 15x and 30x, around the typical market average of roughly 18-22x.
What is MDT return on equity (ROE)?
Medtronic plc's return on equity (ROE) is 10.60%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Medtronic plc's market cap?
Medtronic plc has a market capitalization of $122.05B.
Does MDT pay a dividend?
Yes. Medtronic plc currently yields 3.25%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does MDT carry?
Medtronic plc has a debt-to-equity ratio of 0.56. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is MDT's profit margin?
Medtronic plc reports a net profit margin of 13.93% — the share of revenue left after every cost, including tax and interest.
What sector is MDT in?
Medtronic plc is classified under Healthcare, in the Medical - Devices industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is MDT listed on?
Medtronic plc trades on NYSE under the ticker MDT.
What is MDT's 52-week range?
Over the last year Medtronic plc has traded between $73.31 and $106.33.
Related Healthcare Stocks
Popular Stocks
Screens MDT currently matches
On the figures above, Medtronic plc passes the filters for 11 of our ready-made screens, among them Dividend Stocks, Blue Chip Dividend Stocks, S&P 500 Dividend Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.